Last quarter (Q1 2024), Anixa Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, Anixa Biosciences's net income was $-3.25M. See Anixa Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Oct 23	Oct 22	Oct 21	Oct 20	Oct 19
Total Revenue	$ 210.00K	$ 210.00K	-	$ 512.00K	$ 0.00	$ 250.00K
Cost of Revenue	$ 6.73M	$ 11.22M	$ -13.88M	$ -13.65M	$ 0.00	$ 166.25K
Gross Profit	$ -843.00K	$ 210.00K	$ 13.88M	$ 512.00K	$ 0.00	$ 83.75K
Operating Expense	$ 6.73M	$ 11.22M	$ 13.88M	$ 13.65M	$ 9.98M	$ 11.56M
Operating Income	$ -6.52M	$ -11.01M	$ -13.88M	$ -13.14M	$ -9.98M	$ -11.47M
Net Non Operating Interest Income Expense	$ 1.20M	$ 1.08M	$ 104.00K	$ 2.00K	$ 33.92K	$ 71.35K
Other Income Expense	-	-	-	$ -6.00K	$ -148.08K	$ -418.75K
Pretax Income	$ -5.33M	$ -9.93M	$ -13.77M	$ -13.13M	$ -10.09M	$ -11.82M
Tax Provision	$ -1.74B	$ -1.74B	$ -1.37M	$ -604.00K	-	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -5.24M	$ -9.81M	$ -13.60M	$ -12.95M	$ -10.02M	$ -11.65M
Basic EPS	$ >-0.01	$ 0.32	$ -0.45	$ -0.45	$ -0.45	$ -0.59
Diluted EPS	$ -86.56	$ 0.32	$ -0.45	$ -0.45	$ -0.45	$ -0.59
Basic Average Shares	$ -28.60M	$ 30.98K	$ 30.60M	$ 28.79M	$ 22.23M	$ 19.79M
Diluted Average Shares	$ 124.44K	$ 30.98K	$ 30.37M	$ 28.58M	$ 22.23M	$ 19.79M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 13.47M	$ 22.44M	-	-	$ 9.98M	$ 11.72M
Net Income From Continuing And Discontinued Operation	$ -10.76M	$ -9.81M	$ -13.77M	$ -12.95M	$ -10.02M	$ -11.65M
Normalized Income	$ -1.75B	$ -1.75B	-	-	$ -9.87M	$ -11.23M
Interest Expense	-	-	-	-	-	-
EBIT	$ -5.33M	$ -9.93M	$ -13.77M	$ -13.13M	$ -9.98M	$ -11.47M
EBITDA	$ -5.28M	$ -9.88M	$ -13.73M	$ -13.07M	$ -9.89M	$ -11.00M

Currency in USD

Anixa Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing